Orbimed Advisors Trims $125 After Breakout Year in Biotech
A major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
Utilize inflation protected index funds in retirement to stabilize spending power. Understand integration with core assets and withdrawal strategies.
19,951 articlesA major biotech stake shift signals evolving risk appetite. We break down the $125 million trim by ORBIMED Advisors, ...
A major portfolio move by Deepwater Asset Management shaved nearly half of its stake in Global-E Online. Here’s what ...
A high-profile fund manager dumped a huge chunk of AMD stock in one day. The move sparked questions about portfolio s...
A mid‑sized fund just boosted its stake in ServiceTitan after a sharp share drop. This article unpacks what the move ...
Privacy-focused crypto Zcash is quietly advancing features that could challenge Bitcoin and Ethereum. This in-depth g...
As Tesla fans cheer long-term robotaxi dreams, traders worry about delivery misses. A growing crowd is exploring inve...
Bruno Mars is back with a new solo project, and the tracklist drop isn’t just music news—it’s a case study in modern ...
SpaceX is advancing toward an IPO in mid-June. This guide breaks down what the S-1 reveals, how to assess risk, and p...
Ripple (XRP) faces a crucial test of its technical footing as it hovers near a key support zone. Traders watch for a ...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Oil markets are tight and volatile as global inventories 11-year getting tighter. This guide explains what it means f...
Celebrity headlines can spill into everyday money decisions. This piece breaks down budgeting for weddings, media dra...